Clinical Trial Update: Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

View source ↗

Summary

Clinical trial update evaluating how well plasma circulating tumor DNA (ctDNA) can detect neoplastic disease in asymptomatic individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Pathway Genomics | Conditions: Mutation, Neoplasms | Status: COMPLETED